Gayle Grigson

Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma

C. Lance Cowey, Chirag Amin, Raj S. Pruthi et al. · Journal of Clinical Oncology · 2010 · 198 citations · Full text

Medicine, Oncology, Metastasis +15

Phase II Trial of Sorafenib Plus Interferon Alfa-2b As First- or Second-Line Therapy in Patients With Metastatic Renal Cell Cancer

Jared Gollob, W. Kimryn Rathmell, Tina M. Richmond et al. · Journal of Clinical Oncology · 2007 · 181 citations · Full text

Pharmacy, Oncology, Pharmacology +14

A phase II trial of neoadjuvant erlotinib in patients with muscle‐invasive bladder cancer undergoing radical cystectomy: clinical and pathological results

Raj S. Pruthi, Matthew E. Nielsen, Samuel A. Heathcote et al. · British Journal of Urology · 2010 · 114 citations

Medicine, Oncology, Urology +16

Phase II Trial of Celecoxib in Prostate-Specific Antigen Recurrent Prostate Cancer after Definitive Radiation Therapy or Radical Prostatectomy

Raj S. Pruthi, J. Eric Derksen, Dominic T. Moore et al. · Clinical Cancer Research · 2006 · 97 citations

Medicine, Oncology, Pharmacology +10

A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer

Young E. Whang, Andrew J. Armstrong, W. Kimryn Rathmell et al. · Urologic Oncology Seminars and Original Investigations · 2011 · 87 citations

Medicine, Oncology, Pharmacology +17